Clinical Trial Update: Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for DbXell evaluating its use in adults with mildly uncontrolled Type 2 diabetes mellitus in Phase 1/Phase 2; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DbXell

Snippet

Sponsor: Laniado Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN